Finance

Lists
Why is 300254 up 2.59%?
Dive Deeper
300254:SHE
Shanxi C&Y Pharmaceutical Group Co Ltd
CNÂ¥7.53
+2.59%
(+0.19) 1D
Nov 4, 3:04:49 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300254...
Open
CNÂ¥7.36
High
CNÂ¥7.58
Low
CNÂ¥7.25
Mkt. cap
1.99B
Avg. vol.
8.27M
Volume
8.17M
P/E ratio
83.18
52-wk high
CNÂ¥15.20
52-wk low
CNÂ¥6.93
EPS
CNÂ¥0.09
Shares outstanding
271.19M
No. of employees
1K
Open
CNÂ¥7.36
High
CNÂ¥7.58
Low
CNÂ¥7.25
Mkt. cap
1.99B
Avg. vol.
8.27M
Volume
8.17M
P/E ratio
83.18
52-wk high
CNÂ¥15.20
52-wk low
CNÂ¥6.93
EPS
CNÂ¥0.09
Shares outstanding
271.19M
No. of employees
1K
News stories
From web sources and news partners
About Shanxi C&Y Pharmaceutical Group Co Ltd
CEO-
Employees1.16K
FoundedMar 23, 2005
Headquarters-
SectorPharmaceutical industry
Industry-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
259.31M
173.80M
178.08M
186.37M
Cost of goods sold
87.88M
57.40M
62.11M
72.15M
Cost of revenue
87.88M
57.40M
62.11M
72.15M
Research and development expenses
13.63M
12.74M
11.85M
11.08M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
123.96M
92.97M
88.27M
73.63M
Operating expense
138.78M
106.27M
102.46M
86.86M
Total operating expenses
226.66M
163.67M
164.57M
159.00M
Operating income
32.65M
10.13M
13.51M
27.37M
Other non operating income
9.70M
7.65M
1.96M
-18.66M
EBT including unusual items
13.42M
13.39M
5.80M
25.90M
EBT excluding unusual items
40.89M
13.40M
7.97M
25.28M
Income tax expense
5.46M
5.42M
2.05M
8.64M
Effective tax rate
40.66%
40.50%
35.37%
33.36%
Other operating expenses
-1.34M
902.35K
2.49M
1.65M
Net income
2.52M
3.34M
943.55K
15.52M
Net profit margin
0.97%
1.92%
0.53%
8.33%
Earnings per share
-
-
-
-
Interest and investment income
2.54M
949.72K
-
16.57M
Interest expense
-4.00M
-5.34M
-7.50M
-
Net interest expenses
-1.46M
-4.39M
-7.50M
16.57M
Depreciation and amortization charges
-
-
-
-
EBITDA
45.40M
22.88M
26.99M
40.12M
Gain or loss from assets sale
-8.94M
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps